Researchers used AI to design synthetic viruses intended to combat antibiotic resistance. Critics warn these tools could be repurposed to create lethal pathogens. This tension highlights the gap between medical innovation and biosecurity. Practitioners must now weigh therapeutic gains against the risk of accidental or intentional misuse of generative AI.